DigestRedComo funciona
Red
/
Empresas
On
No verificado

Ono Pharmaceutical Co., Ltd.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosOncologíaSalud

12 Comunicados de prensa

Ver todos los comunicados de prensa
21/04/2026
Eventos
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Ono Pharma Announces Upcoming Presentations at the ASCO 2026 Annual Meeting
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
26/03/2026
Oncología
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
03/03/2026
Mercado laboral
Oncología
Salud
VIH, SIDA y enfermedades autoinmunes
Farmacéutica
Biotecnología
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
15/01/2026
Ciencia
Biotecnología
Salud
Farmacéutica
Sanidad
Oncología
Web y redes sociales
Eventos
Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
12/01/2026
Eventos
Web y redes sociales
Ciencia
Sanidad
Biotecnología
Farmacéutica
Salud
Oncología
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
09/10/2025
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Industria
Ono Announces ONO-4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
09/10/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
23/06/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Mercado laboral
Industria
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
28/05/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
ONO PHARMA Presents Positive Results From Pivotal Trial in U.S. Patients With Relapsed or Refractory PCNSL at 2025 ASCO Annual Meeting
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
24/04/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0